To include your compound in the COVID-19 Resource Center, submit it here.

AGIX-4207: Phase II failed

The 12-week, double-blind, placebo-controlled, European OSCAR Phase II

Read the full 83 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE